Stockscreener 앱 받기
124.91
3.01%
3.65
Gilead Sciences Inc 주식(GILD)의 최신 뉴스
Csenge Advisory Group Has $2.38 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Sold by QRG Capital Management Inc. - MarketBeat
HER2-Negative Metastatic Breast Cancer Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Genentech, AstraZeneca, Merck Sharp & Dohme LLC, Gilead Sciences, BeiGene, Eisai - Barchart.com
Insider Sell: Andrew Dickinson Sells 3,000 Shares of Gilead Scie - GuruFocus
Andrew Dickinson Sells 3,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock - MarketBeat
Gilead Sciences (NASDAQ:GILD) Insider Johanna Mercier Sells 3,000 Shares of Stock - MarketBeat
Gilead Sciences CCO Mercier sells $372,930 in stock - Investing.com
Gilead Sciences CFO Dickinson sells $372,930 in stock - Investing.com India
The Truth About Gilead Sciences: Is This ‘Boring’ Pharma Stock About To Blow Up? - AD HOC NEWS
Hedge Fund Moves: Whats the analyst consensus on Gilead Sciences IncWeekly Profit Recap & Fast Gain Stock Tips - baoquankhu1.vn
Gilead: A Top GARP Biotech Play, But Momentum Weakens (Downgrade) (NASDAQ:GILD) - Seeking Alpha
Looking Into Gilead Sciences Inc's Recent Short Interest - Benzinga
Gilead Sciences, Inc. $GILD Shares Purchased by Ritholtz Wealth Management - MarketBeat
Short Covering: Is GCTSWS stock a good pick for beginnersJuly 2025 Chart Watch & Expert Approved Trade Ideas - baoquankhu1.vn
Gilead stock holds Buy rating at UBS as Yeztugo launch shows promise - Investing.com
Gilead Sciences, Inc. $GILD Shares Sold by Conning Inc. - MarketBeat
JPM26: Gilead Captures Sunny JPM Mood With Yeztugo Numbers, HIV Vibes - BioSpace
Gilead Sciences, Inc. (GILD) Stock Analysis: Strong Buy Ratings and 10.84% Potential Upside - DirectorsTalk Interviews
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Manning & Napier Advisors LLC Has $13.65 Million Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
GILD Stock Price, Forecast & Analysis | GILEAD SCIENCES INC (NASDAQ:GILD) - Chartmill
Gilead Sciences CFO Andrew Dickinson sells $14 million in stock - MSN
A Look At Gilead Sciences (GILD) Valuation After JP Morgan Conference HIV Pipeline Update - Sahm
GILD: Morgan Stanley Lowers Price Target for Gilead Sciences | G - GuruFocus
Morgan Stanley Issues Pessimistic Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price - MarketBeat
Gilead Sciences stock rating reiterated at Outperform by BMO Capital - Investing.com
Nordea Investment Management AB Has $494.03 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Acquired by TD Private Client Wealth LLC - MarketBeat
Liberty One Investment Management LLC Increases Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Acquired by PKO Investment Management Joint Stock Co - MarketBeat
Polaris Capital Management LLC Sells 12,500 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead price tries to regain footingForecast today13-01-2026 - Economies.com
Kymera Therapeutics Outlines Key 2026 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs - GlobeNewswire Inc.
Gilead Sciences, Inc. (NASDAQ:GILD) Is a Favorite Amongst Institutional Investors Who Own 88% - 富途牛牛
Gilead Sciences (GILD) Surpasses Market Returns: Some Facts Worth Knowing - sharewise.com
Gilead Expects FDA Decision on Anito-Cel in First Quarter of 2026 - Precision Medicine Online
Gilead Sciences: From All-Time Highs To Higher Highs (NASDAQ:GILD) - Seeking Alpha
Gilead’s new HIV prevention shot added to CVS’s drug coverage lists, CEO says - 104.1 WIKY
Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says - Reuters
Gilead Sciences to Seek Bolt-On Value-Creating Acquisitions - marketscreener.com
Sumitomo Mitsui Trust Group Inc. Buys 27,232 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Meeder Asset Management Inc. Has $16.76 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Nexus Investment Management ULC Buys 21,220 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Tema Etfs LLC Buys 25,912 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Inside Gilead’s 2030 Strategy to Advance 10 Transformative Therapies - Endpoints News
9,809 Shares in Gilead Sciences, Inc. $GILD Bought by Elite Wealth Management Inc. - MarketBeat
UBS and Citi Go Bullish on Gilead Sciences (GILD) - Insider Monkey
The Bull Case For Gilead Sciences (GILD) Could Change Following New OncoNano Drug-Delivery Collaboration - Yahoo Finance
Is Gilead Sciences (GILD) Pricing Reflecting Recent 38.5% One Year Share Return? - Yahoo Finance
New York State Teachers Retirement System Has $121.45 Million Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Philip James Wealth Mangement LLC Lowers Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences (GILD) Stock Outlook: Mizuho Lifts Target Amid Stronger Biktarvy Timeline - MSN
Gilead price target raised to $154 from $144 at BofA - Yahoo Finance
Oregon Public Employees Retirement Fund Acquires 34,235 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
HB Wealth Management LLC Buys 13,249 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences Inc. (GILD) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
BofA Securities raises Gilead Sciences stock price target to $154 on HIV franchise strength - Investing.com
Gilead Sciences, Inc. $GILD Position Lessened by Capital Investment Advisors LLC - MarketBeat
Gilead Names Wettan Executive Vice President - BioXconomy
Will Gilead Sciences Inc. stock attract ESG investorsJuly 2025 Technicals & Real-Time Buy Signal Notifications - ulpravda.ru
Gilead (GILD) Recalls Veklury Due to Contaminant Concerns - GuruFocus
What is the fair value of Gilead Sciences Inc. stock now2025 Top Gainers & Risk Controlled Stock Alerts - ulpravda.ru
Gilead presents positive data on liver fibrosis treatments - The Pharma Letter
The Escalator: Argenx, Gilead Sciences, Bristol Myers Squibb and more - Medical Marketing and Media
Gilead Sciences posts falling sales and profits, as CEO announces departure - The Pharma Letter
Gilead Sciences, Inc. $GILD Holdings Decreased by Commonwealth Equity Services LLC - MarketBeat
Today's Analyst Action: Citigroup Raises Gilead Sciences (GILD) Price Target | GILD Stock News - GuruFocus
Citigroup Boosts Gilead Sciences (NASDAQ:GILD) Price Target to $140.00 - MarketBeat
UBS Raises Gilead Sciences (GILD) Price Target to $145 and Upgra - GuruFocus
0.93%
0.12%
자본화:
|
볼륨(24시간):